Mostrar el registro sencillo del ítem

dc.contributor.authorAraujo-Abad, Salome
dc.contributor.authorRizzuti, Bruno
dc.contributor.authorVidal, Miguel
dc.contributor.authorAbian, Olga
dc.contributor.authorFarez Vidal, María Esther 
dc.contributor.authorVelázquez Campoy, Adrián
dc.contributor.authorDe Juan Romero, Camino
dc.contributor.authorNeira, José Luis
dc.date.accessioned2024-07-18T11:21:11Z
dc.date.available2024-07-18T11:21:11Z
dc.date.issued2024-05-07
dc.identifier.citationAraujo-Abad, S.; Rizzuti, B.; Vidal, M.; Abian, O.; Fárez-Vidal, M.E.; Velazquez-Campoy, A.; de Juan Romero, C.; Neira, J.L. Unveiling the Binding between the Armadillo- Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBP. Biomolecules 2024, 14, 561. [https://doi.org/10.3390/biom14050561]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/93227
dc.description.abstractPlakophilin 1 (PKP1), a member of the p120ctn subfamily of the armadillo (ARM)-repeatcontaining proteins, is an important structural component of cell–cell adhesion scaffolds although it can also be ubiquitously found in the cytoplasm and the nucleus. RYBP (RING 1A and YY1 binding protein) is a multifunctional intrinsically disordered protein (IDP) best described as a transcriptional regulator. Both proteins are involved in the development and metastasis of several types of tumors. We studied the binding of the armadillo domain of PKP1 (ARM-PKP1) with RYBP by using in cellulo methods, namely immunofluorescence (IF) and proximity ligation assay (PLA), and in vitro biophysical techniques, namely fluorescence, far-ultraviolet (far-UV) circular dichroism (CD), and isothermal titration calorimetry (ITC). We also characterized the binding of the two proteins by using in silico experiments. Our results showed that there was binding in tumor and non-tumoral cell lines. Binding in vitro between the two proteins was also monitored and found to occur with a dissociation constant in the low micromolar range (~10 μM). Finally, in silico experiments provided additional information on the possible structure of the binding complex, especially on the binding ARM-PKP1 hot-spot. Our findings suggest that RYBP might be a rescuer of the high expression of PKP1 in tumors, where it could decrease the epithelial–mesenchymal transition in some cancer cells.es_ES
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/Feder, EU)es_ES
dc.description.sponsorshipPID2021-127296OB-I00 to A.V.-C. and CP19/00095 to C.d.J.Res_ES
dc.description.sponsorshipFondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”)es_ES
dc.description.sponsorshipPI21/00394 to O.A. and PI22/00824 to C.d.J.R.es_ES
dc.description.sponsorshipPAIDI program, Group BIO309es_ES
dc.description.sponsorshipJunta de Andalucía and Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III, grant number PI10/00198, to M.E.F.- V.es_ES
dc.description.sponsorshipDiputación General de Aragón, grant numbers E45-20R to A.V.-C. and B25-20R to O.A.es_ES
dc.description.sponsorshipConsellería de Innovación, Universidades, Ciencia y Sociedad Digital (Comunidad Valenciana), grant number CIAICO 2021/0135 to J.L.N. and C.d.J.R.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectImmunofluorescencees_ES
dc.subjectProtein-protein interactionses_ES
dc.subjectIntrinsically disordered proteines_ES
dc.titleUnveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBPes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/biom14050561
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional